Effect of New Evidence on Antithrombotic Therapies in Atrial Fibrillation Patients Who Undergo Percutaneous Coronary Intervention in Alberta, Canada

Background: Trials have addressed the combined use of direct oral anticoagulants (DOACs) and antiplatelets in atrial fibrillation (AF) patients undergoing percutaneous coronary intervention (PCI). These trials may have changed prescribing patterns. Methods: This administrative audit of Albertans wit...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Theresa E. Eberhardt, PharmD, ACPR, Tammy J. Bungard, BSP, PharmD, Michelle M. Graham, MD, FRCPC, FCCS, Michelle Picard, BScPharm, ACPR, Grace T. Wang, MMath, Margaret L. Ackman, BScPharm, PharmD, ACPR, FCSHP
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Elsevier 2022-04-01
Seri Bilgileri:CJC Open
Online Erişim:http://www.sciencedirect.com/science/article/pii/S2589790X21003565
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller